1 completed, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow CBLB502: new trials by email Literature Review of CBLB502 trials Research Report on CBLB502
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination Entolimod, Placebo, Influenza vaccine - Healthy | Phase 2 | Completed | Robert J. Pignolo | 61 | 2019-10-30 | 2023-06-22 |
| Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer CBLB502, Placebo - Colorectal Cancer | Phase 2 | Unknown | BioLab 612 LLC | 40 | 2015-11-01 | 2017-02-09 |
Colorectal Neoplasms (1) · Influenza, Human (1)
BioLab 612 LLC (1) · Robert J. Pignolo (1)
Russia (1) · United States (1)
Nikolay V. Kislov, MD PhD (1) · Robert Pignolo, MD, PhD (1) · Sergei I. Achkasov, MD PhD (1) · Sergei V. Odintcov, MD PhD (1)